5.1 Market Status Quo and Forecast
Enteral nutrition preparations are the main varieties in enteral nutrition support treatment. The oral enteral nutrition emulsion and suspension include TPF, TP, TPF-T and TP-HE etc different formulas. The main manufacturers are Sino-Swed Pharmaceutical Corp, Ltd. (SSPC) and Nutricia (Wuxi), the former mainly includes such brands as: Fresubin Energy Fibre, Fresubin, Supportan and Fresubin MCT 750; while the later mainly includes Nutrison fibre, Nutrison, Peptisorb Liquid and Diason etc brands.
In China, the clinical nutrition market started in 1960s-70s. After entered into China market in 1982, China-Germany joint venture Sino-Swed Pharmaceutical is the first enterprise launching fat emulsion, amino acid and other products into market. With tens of years of development, the market is segmented increasingly, each variety increases rapidly.
In recent years, with the popularization of clinical nutrition conception in China, more and more domestic enterprises set foot in this field. According to statistics, in 2010, the market scale of enteral nutrition preparation was CNY 2.21 billion in China, by the end of 2014, it was CNY 4.11 billion and increases continually.
In overall, at present, the clinical nutrition is still in development stage in China, the home-made clinical nutrition preparations still far lag behind overseas level in respects of both quality and variety, the high-grade product market is monopolized by the imported or joint-venture products. With the constant upgrades of clinical academic concepts, from the original intravenous hyperalimentation, to equal nitrogen, equal thermal treatment, to low nitrogen, low calorie parenteral nutrition solution, to enteral nutrition and to joint nutrition treatment theory, higher requirements on convenience and safety of clinical nutrition products are put forward, especially, the emergence of infusion method of “All-in-one” nutrient solution makes the concept: parenteral nutrition should give the most reasonable infusion method, become common sense clinically.
5.2 Demand Analysis and Forecast
Statistics date suggests: in enteral nutrition products, the market ratio of standard formula is the highest, hitting 77%, the special formula accounts for 17%
1. Overview of China's Enteral Nutrition Preparation Product
1.1 Definition, Property and Application Characteristics
1.2 Development History
2. Enteral Nutrition Preparation in Overseas Markets
2.1 Summary
2.2 Overview of Asia Market
2.3 Europe Market
2.4 American Market
3. Environment Analysis of Enteral Nutrition Preparation
3.1 Economic Development Environment in China
3.1.1 GDP Change Track
3.1.2 Fixed Assets Investment Change Track
3.1.3 Import & Export Trade Change Track
3.1.4 Macroeconomic Development Forecast
3.2 Relevant Industrial Policies, Laws, Regulations and Standards
3.2.1 Relevant Regulations in China
3.2.2 Relevant Regulations in Foreign Countries
4. Market Characteristics of Enteral Nutrition Preparation
4.1 Market Concentration Rate and Forecast
4.2 SWOT Analysis and Forecast
4.2.1 Strengths
4.2.2 Weakness
4.2.3 Opportunity
4.2.4 Threats
4.3 Market Entry and Exit and Forecast
4.4 Substitute products and Forecast
5. Development of Enteral Nutrition Preparation in China
5.1 Market Status Quo and Forecast
5.2 Demand Analysis and Forecast
5.3 Price Trend
5.3.1 Price Trend, 2010-2014
5.3.2 Current Price and Analysis
5.3.3 Future Price Trend, 2015-2020
6. Analysis on Enteral Nutrition Preparation in China
6.1 Analysis on Enteral Nutrition Preparation in China
6.2 Future Market Capacity
6.3 Current Industry Development Characteristics
6.4 SWOT Analysis
6.4.1 Advantageous Factors
6.4.2 Disadvantageous Factors
7. of Import & Export Analysis
7.1 Import Analysis
7.2 Export Analysis
8 Technical Development of Enteral Nutrition Preparation in China
8.1 Development Status Quo
8.2 Technical Readiness
8.3 Future Development Strategies
9. Key Manufacturers and Competition Pattern in China
9.1 Netherlands Nutricia
9.1.1 Company Profile
9.1.2 Business Performance
9.1.3 Market Shares
9.1.4 Development Strategies
9.2 Sino-Swed Pharmaceutical Corp, Ltd. (SSPC)
9.2.1 Company Profile
9.2.2 Business Performance
9.2.3 Market Shares
9.2.4 Development Strategies
9.3 Abbott Laboratories
9.3.1 Company Profile
9.3.2 Business Performance
9.3.3 Market Shares
9.3.4 Development Strategies
9.4 NOVARTIS Pharmaceutical Co.,Ltd
9.4.1 Company Profile
9.4.2 Business Performance
9.4.3 Market Shares
9.4.4 Development Strategies
9.5 Xi'an Libang Clinical Nutrition Limited Company
9.4.1 Company Profile
9.4.2 Business Performance
9.4.3 Market Shares
9.4.4 Development Strategies
10 Investment Suggestions on Enteral Nutrition Preparation in China
10.1 Investment Environment
10.2 Investment Risks
10.3 Investment Suggestions
11. Future Development Forecast and Investment Prospect Analysis
11.1 Future Industry Development Trend
11.2 Industry Operation Forecast, 2012 to 2015
11.2.1 Gross Industrial Output Value, 2012 to 2015
11.2.2 Sales Revenues, 2012 to 2015
11.2.3 Total Industry Assets, 2012 to 2015
12 Investment Suggestions and Opinions from Industry Experts
12.1 Investment Opportunity
12.2 Investment Risks
12.3 Countermeasures
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : November 2019
$ 3600
Published On : October 2019
$ 2950
Published On : October 2019
$ 2950
Published On : October 2019
$ 2950
